https://www.resalistherapeutics.com/bio-ceo-2023-new-york/2023-05-02T13:08:34+01:00https://www.resalistherapeutics.com/bio-europe-spring-2023-basel/2023-05-02T13:08:41+01:00https://www.resalistherapeutics.com/lsx-world-congress-2023-london/2023-05-10T15:33:33+01:00https://www.resalistherapeutics.com/bio-international-convention-2023-boston/2023-06-12T11:32:25+01:00https://www.resalistherapeutics.com/bioequity-europe-2023-dublin/2023-05-22T12:06:07+01:00https://www.resalistherapeutics.com/resalis-therapeutics-announces-seed-financing-of-e10-million-to-fund-non-coding-rna-based-therapeutics-for-metabolic-diseases/2024-01-04T09:32:54+00:00https://www.resalistherapeutics.com/easl-congress/2023-06-13T14:25:34+01:00https://www.resalistherapeutics.com/oligonucleotide-therapy-society-annual-meeting/2023-10-23T08:25:53+01:00https://www.resalistherapeutics.com/aasld-the-liver-meeting/2023-10-23T08:24:20+01:00https://www.resalistherapeutics.com/bioeurope-fall/2023-09-08T18:24:56+01:00https://www.resalistherapeutics.com/biojapan/2023-09-27T15:47:32+01:00https://www.resalistherapeutics.com/luncheon-pitch-session/2023-09-27T15:48:15+01:00https://www.resalistherapeutics.com/jefferies-healthcare-conference/2023-10-23T08:25:26+01:00https://www.resalistherapeutics.com/j-p-morgan-healthcare-conference/2023-12-22T10:38:48+00:00https://www.resalistherapeutics.com/resalis-therapeutics-raises-e10-million-series-a-to-complete-first-clinical-trial-for-res-010-in-obesity/2024-10-21T16:46:18+01:00https://www.resalistherapeutics.com/lsx-world-congress/2024-01-25T11:59:35+00:00https://www.resalistherapeutics.com/european-congress-on-obesity/2024-01-25T12:02:49+00:00https://www.resalistherapeutics.com/resalis-therapeutics-appoints-almut-nitsche-as-chief-medical-and-development-officer-2/2024-02-01T10:04:36+00:00https://www.resalistherapeutics.com/mash-and-fibrosis-keystone-symposium/2024-02-06T08:35:46+00:00https://www.resalistherapeutics.com/rna-leaders-europe/2024-02-06T09:18:28+00:00https://www.resalistherapeutics.com/easd2024/2024-07-24T13:16:24+01:00https://www.resalistherapeutics.com/rna-society-annual-meeting/2024-04-23T10:45:56+01:00https://www.resalistherapeutics.com/international-congress-on-obesity/2024-02-06T09:21:52+00:00https://www.resalistherapeutics.com/easl-congress-2024/2024-02-06T09:23:52+00:00https://www.resalistherapeutics.com/2024oligomeeting/2024-07-25T14:20:04+01:00https://www.resalistherapeutics.com/5th-nnab-medicine-industry-network-meeting/2024-09-09T08:24:53+01:00https://www.resalistherapeutics.com/the-new-key-words-in-the-management-of-masld-innovation-prevention-and-multi-disciplinarity/2024-09-09T08:30:58+01:00https://www.resalistherapeutics.com/bioeurope-2024/2024-10-22T14:27:05+01:00https://www.resalistherapeutics.com/jpm-healthcare-conference-2025/2024-10-25T10:23:13+01:00https://www.resalistherapeutics.com/1st-annual-biopharma-obesity-innovation-forum/2024-10-25T10:25:57+01:00https://www.resalistherapeutics.com/keystone-symposia-2025/2024-10-25T10:39:26+01:00https://www.resalistherapeutics.com/resalis-therapeutics-gains-strategic-equity-investment-from-sanofi/2024-10-28T10:00:29+00:00https://www.resalistherapeutics.com/resalis-therapeutics-announces-initiation-of-phase-1-clinical-trial-for-res010-in-obesity/2024-12-03T10:00:23+00:00https://www.resalistherapeutics.com/smot-2025/2025-01-24T09:18:01+00:00https://www.resalistherapeutics.com/rna-leaders-2025/2025-01-24T09:29:08+00:00https://www.resalistherapeutics.com/rna-symposium-2025/2025-03-11T14:01:15+00:00https://www.resalistherapeutics.com/easd-early-career-academy-meeting/2025-03-11T13:59:08+00:00https://www.resalistherapeutics.com/easl-congress-2025/2025-05-05T09:37:14+01:00https://www.resalistherapeutics.com/easd-early-career-academy-meeting-2/2025-05-05T09:48:04+01:00https://www.resalistherapeutics.com/ada-conference/2025-06-18T11:53:04+01:00https://www.resalistherapeutics.com/edm-world-congress/2025-06-18T11:57:29+01:00https://www.resalistherapeutics.com/odd-summit/2025-06-18T12:02:38+01:00https://www.resalistherapeutics.com/odd-summit-2/2025-07-07T15:57:17+01:00https://www.resalistherapeutics.com/odd-summit-3/2025-07-07T16:00:53+01:00https://www.resalistherapeutics.com/odd-summit-4/2025-08-25T10:13:23+01:00https://www.resalistherapeutics.com/resalis-therapeutics-reports-durable-fat-selective-weight-loss-with-res-010-in-non-human-primates-at-multiple-scientific-and-industry-meetings/2025-10-07T10:01:31+01:00https://www.resalistherapeutics.com/odd-summit-4-2/2025-10-14T13:43:41+01:00https://www.resalistherapeutics.com/odd-summit-4-2-2/2025-10-14T13:45:36+01:00https://www.resalistherapeutics.com/odd-summit-4-2-2-2/2025-10-14T13:47:45+01:00https://www.resalistherapeutics.com/obesity-keystone-symposium/2025-10-15T10:34:22+01:00https://www.resalistherapeutics.com/obesity-keystone-symposium-2/2025-10-21T13:54:44+01:00https://www.resalistherapeutics.com/obesity-keystone-symposium-2-2/2025-10-21T13:58:14+01:00https://www.resalistherapeutics.com/resalis-therapeutics-appoints-sandor-batkai-as-medical-director/2026-01-22T10:01:04+00:00https://www.resalistherapeutics.com/tides-oligonucleotide-and-peptide-therapeutics/2026-03-31T09:02:44+01:00https://www.resalistherapeutics.com/bio-international-convention/2026-05-11T16:11:56+01:00https://www.resalistherapeutics.com/rnatx-2026/2026-05-11T16:11:30+01:00https://www.resalistherapeutics.com/resalis-announces-initiation-of-phase-1b-clinical-study-evaluating-res-010-as-treatment-to-address-unmet-needs-in-obesity/2026-06-29T10:01:11+01:00